Can I read Anktiva: IL-15 Agonist for Bladder Cancer on EtoBox?

Anktiva: IL-15 Agonist for Bladder Cancer by draishwaryasunil27 is a document available to read on EtoBox.

What is Anktiva: IL-15 Agonist for Bladder Cancer about?

ANKTIVA (nogapendekin alfa inbakicept-pmln) is an interleukin-15 receptor agonist indicated for adult patients with BCG-unresponsive nonmuscle invasive bladder cancer. It works by activating NK, CD8+, and memory T cells while avoiding the proliferation of immuno-suppressive Treg cells. Common side effects include dysuria, hematuria, urinary frequency, and urinary tract infections.

Author

draishwaryasunil27

Language

EN